30 Mar 2026Open access
Resistance gene profiling of beta-lactamase and carbapenemase in gram-negative blood isolates: A tertiary care hospitalPublisher sitePLoS ONE, Antibiotic Resistance in Bacteria
UniversitiesAbera Admasie
Active, last published 2026
In salmonella and campylobacter epidemiology
Abera
Admasie
Scholar“Research focused on Salmonella and Campylobacter epidemiology and adjacent fields.”
Arba Minch University
Claim Your Profile3
H-index
26
Citations
Abera has not officially claimed their profile. If you are Abera, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
bera Admasie is a researcher working on Salmonella and Campylobacter epidemiology. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Abera's work has been cited 26 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Salmonella and Campylobacter epidemiology×6Food Safety and Hygiene×4Viral gastroenteritis research and epidemiology×3
04 · Where I am
Affiliations
Affiliation on published researchArba Minch UniversityDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works19 Aug 2024Open access4cites
Genomic diversity of Campylobacter jejuni and Campylobacter coli isolated from the Ethiopian dairy supply chainPublisher sitePLoS ONE, Salmonella and Campylobacter epidemiology
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Abera?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you